The RightMed® comprehensive test is a provider-ordered pharmacogenomic test that analyzes a patient’s DNA to determine how he or she may respond to hundreds of medications used to treat and manage many medical conditions. With the help of the RightMed tools and services, providers can identify which medications may — or may not — work best for the patient. This may lead to more effective prescriptions, fewer side effects, and less trial and error to find the right medication.
The RightMed comprehensive test covers hundreds of commonly prescribed medications, including omeprazole (Prilosec), simvastatin (Zocor), citalopram (Celexa), clopidogrel (Plavix), warfarin (Coumadin), codeine, morphine, alprazolam (Xanax), phenytoin (Dilantin), metoprolol (Lopressor), plus many more.
The RightMed comprehensive test covers medications used for many medical conditions.
The RightMed comprehensive test analyzes genes involved in drug metabolism, drug targets, drug receptors, and drug transporters. Analysis is provided for genes that have been shown, based on OneOme's rigorous research and standards for inclusion, to affect how a patient responds to many commonly prescribed medications.
hCV32407220 (rs765776661) NM_000106.5:c.1411_1412insTGCCCACTG
HLA00097 NM_002116 (interrogated at exon 2)
HLA00386 NM_005514 (interrogated at exon 2 and intron 2)
HLA00381 NM_005514 (interrogated at exon 3)
† MTHFR is available as optional, complimentary add-on to the RightMed comprehensive test.
Learn more about these genes, including their impact on medication response and any guidelines associated with them.
Test results are presented in the RightMed comprehensive test report, which categorizes medications into a simple, easy-to-read format:
Given that a patient's DNA doesn't change, the test results can be used to guide medication and dosage decisions for years to come.
Providers also get access to the RIGHTMED ADVISOR, an interactive tool to help providers quickly and easily interpret test results, explore more information about the hundreds of medications in OneOme’s database, evaluate drug-to-drug interactions, and view curated medication alternatives.
Providers can generate custom reports by selecting the medications they would like displayed in a RightMed Advisor custom report, which helps providers get more in-depth information and focus on the drugs that matter the most for each patient.
In addition to the RightMed comprehensive test report, providers can choose to receive additional reports in order to get easy access to the most relevant information.
RightMed Advisor reports are customized reports that provide in-depth information on the medications that are most relevant to the patient. Speciality reports, including our psychiatry and oncology reports, include a subset of medications that are most relevant for a specific medical speciality.
If you are a patient, learn more about the RightMed test and how to get it by downloading our PATIENT TOOLKIT.